iRhythm Technologies, Inc. (IRTC)

NASDAQ: IRTC · Real-Time Price · USD
75.47
-1.39 (-1.81%)
At close: Nov 19, 2024, 4:00 PM
75.48
+0.01 (0.01%)
After-hours: Nov 19, 2024, 4:02 PM EST
-1.81%
Market Cap 2.36B
Revenue (ttm) 560.03M
Net Income (ttm) -150.66M
Shares Out 31.30M
EPS (ttm) -4.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 491,423
Open 76.09
Previous Close 76.86
Day's Range 75.02 - 76.96
52-Week Range 55.92 - 124.12
Beta 1.23
Analysts Strong Buy
Price Target 107.78 (+42.81%)
Earnings Date Oct 30, 2024

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Oct 20, 2016
Employees 2,000
Stock Exchange NASDAQ
Ticker Symbol IRTC
Full Company Profile

Financial Performance

In 2023, iRhythm Technologies's revenue was $492.68 million, an increase of 19.90% compared to the previous year's $410.92 million. Losses were -$123.41 million, 6.24% more than in 2022.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price forecast is $107.78, which is an increase of 42.81% from the latest price.

Price Target
$107.78
(42.81% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economi...

1 day ago - GlobeNewsWire

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

14 days ago - GlobeNewsWire

iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presi...

20 days ago - Seeking Alpha

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients

20 days ago - GlobeNewsWire

iRhythm Technologies Announces Third Quarter 2024 Financial Results

SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) --  iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve...

20 days ago - GlobeNewsWire

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent dise...

22 days ago - GlobeNewsWire

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

On Monday, the FDA approved iRhythm Technologies, Inc.'s IRTC 510(k) submission related to prior design changes to the Zio AT device via letter to file.

4 weeks ago - Benzinga

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients Zio AT...

4 weeks ago - GlobeNewsWire

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

4 weeks ago - GlobeNewsWire

Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm

PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company's long-term sharehold...

2 months ago - GlobeNewsWire

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

SAN FRANCISCO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...

2 months ago - GlobeNewsWire

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

iRhythm's next-generation Zio ® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio ® XT device. Longer wear duration and analyzable time may further imp...

2 months ago - GlobeNewsWire

iRhythm Technologies Announces Results of GUARD-AF Trial

GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm's Zio ® patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest randomized...

2 months ago - GlobeNewsWire

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

2 months ago - GlobeNewsWire

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

3 months ago - GlobeNewsWire

iRhythm Technologies, Inc. (IRTC) Q2 2024 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presid...

3 months ago - Seeking Alpha

iRhythm Technologies Announces Chief Financial Officer Transition

SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve...

3 months ago - GlobeNewsWire

iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

4 months ago - GlobeNewsWire

This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

Other symbols: SWKSBFHOCULTRU
5 months ago - Benzinga

iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation

SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

5 months ago - GlobeNewsWire

iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference

SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

6 months ago - GlobeNewsWire

iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent ...

6 months ago - GlobeNewsWire

iRhythm Technologies, Inc. (IRTC) Q1 2024 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice B...

7 months ago - Seeking Alpha

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

7 months ago - GlobeNewsWire

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhy...

8 months ago - Accesswire